Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1956 1
1957 2
1959 1
1960 1
1961 2
1962 2
1964 1
1966 4
1967 2
1968 4
1969 1
1970 1
1971 12
1972 7
1973 2
1974 7
1975 1
1976 2
1977 6
1978 6
1979 10
1980 9
1981 16
1982 13
1983 21
1984 12
1985 19
1986 31
1987 38
1988 40
1989 48
1990 43
1991 36
1992 59
1993 62
1994 81
1995 77
1996 74
1997 72
1998 90
1999 116
2000 155
2001 159
2002 213
2003 231
2004 260
2005 381
2006 436
2007 466
2008 492
2009 645
2010 764
2011 895
2012 903
2013 1020
2014 1200
2015 1388
2016 1462
2017 1635
2018 1778
2019 1928
2020 2405
2021 2730
2022 3236
2023 3185
2024 3349
2025 3971
2026 3271
2027 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35,600 results

Results by year

Filters applied: . Clear all
Page 1
Cysteine excess triggers a mitochondrial iron-dependent cell death.
Nakamura T, Inoki A, Das NK, Chen B, Khan A, Liu Y, Uygur B, Yen FS, Unlu G, Shah YM, Birsoy K. Nakamura T, et al. Among authors: chen b. Nat Metab. 2026 Sep 15. doi: 10.1038/s42255-026-01616-7. Online ahead of print. Nat Metab. 2026. PMID: 42744910
Fibroblasts restrain gut inflammation by IGF1-dependent regulation of innate lymphocytes.
Lin Q, Liu RE, Wang Q, Kang L, Chen B, Lu Y, Zhang Y, Gu Z, Zhou Y, Liu H, Xu X, Cao Z, Tang Z, Xu W, Wang Y, Cui Z, Yu M, Jin S, Zhang Q, Liu C, Tang H, Hu X, Sonnenberg GF, Chu C, Zhou L. Lin Q, et al. Among authors: chen b. Science. 2026 Sep 24;393(6818):1347-1353. doi: 10.1126/science.aei0062. Epub 2026 Sep 24. Science. 2026. PMID: 42784669
Uneven attention to climate tipping points.
Wang H, Chen B, Ma F, Wunderling N, Lenton TM, Tzachor A. Wang H, et al. Among authors: chen b. Proc Natl Acad Sci U S A. 2026 Oct 6;123(40):e2618666123. doi: 10.1073/pnas.2618666123. Epub 2026 Sep 28. Proc Natl Acad Sci U S A. 2026. PMID: 42804648 Free PMC article.
A randomized, double-blind, active-controlled phase 3 multicenter trial of rHSA for cirrhotic ascites.
Jia J, An Y, Ou X, Duan W, Li Y, Deng Y, Xie J, Wang Q, Li X, Pan Z, Luo Y, Wang L, Zhong X, Wu D, Meng Z, Liu Z, Chen Z, Hong L, Zong Y, Tang Y, Zhong L, Wo C, Xu B, Shu B, Shi F, Li G, Xiao G, Song F, Zhang G, Chen H, Liao A, Wei H, Li J, An X, Li F, Pan C, Pan J, Lin Z, Hou W, Li H, Chen J, Wu X, Sun S, Shen Y, Zhu X, Chen B, Zeng Y, Xiao X, Geng J, Zhang H, Zhao C, Chen L, Wu Q, Li Y, Liu X, Jiang X, Tian H, Li Z, Zhao M, Li H, Xiong X, Yao R, Shao L, Liu F, Fu L, Liao Y, Guan T, Luo X, Yuan W, Ji H, Zhou X, Luo Y. Jia J, et al. Among authors: chen b. Signal Transduct Target Ther. 2026 Sep 10;11(1):390. doi: 10.1038/s41392-026-02951-7. Signal Transduct Target Ther. 2026. PMID: 42760319 Free PMC article. Clinical Trial.
Cancer-Associated Fibroblasts Promote Glucose Metabolic Reprogramming and Progression of Triple-Negative Breast Cancer via Exosomal circFAD104-Mediated Intercellular Communication.
Wang L, Li X, Liang Y, Wang Y, Jin Y, Wang J, Luo D, Yang Y, Yang J, Li Y, Chen T, Han D, Wang Z, Zhao W, Chen B, Wang L, Yang Q. Wang L, et al. Among authors: chen b. Adv Sci (Weinh). 2026 Aug 29:e77504. doi: 10.1002/advs.77504. Online ahead of print. Adv Sci (Weinh). 2026. PMID: 42667179 Free PMC article.
The eyes and Parkinsonian syndromes.
Chen BS, Sandlin DS, Biousse V. Chen BS, et al. Rev Neurol (Paris). 2026 Sep 30:S0035-3787(26)00607-7. doi: 10.1016/j.neurol.2026.09.005. Online ahead of print. Rev Neurol (Paris). 2026. PMID: 42816189 Review.
Felzartamab plus lenalidomide-dexamethasone versus lenalidomide-dexamethasone for relapsed or refractory multiple myeloma: an open-label, parallel-controlled, randomised, phase 3 trial.
He H, Shang J, Wang Y, Xia Z, Zhu F, Yang Y, Fang B, Chen W, Chen B, Cai Z, Zhou H, Li Y, Liu H, Chen L, Liu Y, Huang Z, Zeng P, Jin J, Li Y, Mi J, Zhou Z, Gao S, Xi Y, Wang Q, Chang C, Du X, Huang SY, Wang HY, Ko PS, Shao Z, Luo J, Wang S, Huang J, Dai M, Yang T, Zhan R, Liang B, Wang MC, Wu S, Zhong L, Wei Y, Wang H, Wu H, Li J, Teng CL, Meng Y, Wu M, Yang P, Chen X, Zhu AX, Fu W, Wu D, Fu C. He H, et al. Among authors: chen b. Lancet Haematol. 2026 Oct;13(10):e722-e736. doi: 10.1016/S2352-3026(26)00223-1. Lancet Haematol. 2026. PMID: 42822478 Clinical Trial.
35,600 results
You have reached the last available page of results. Please see the User Guide for more information.